The store will not work correctly when cookies are disabled.
Sodium 5-cyclopropylbenzo[h]isoquinoline-8-carboxylate
ID: ALA4862119
PubChem CID: 137464229
Max Phase: Preclinical
Molecular Formula: C17H12NNaO2
Molecular Weight: 263.30
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C([O-])c1ccc2c(c1)cc(C1CC1)c1ccncc12.[Na+]
Standard InChI: InChI=1S/C17H13NO2.Na/c19-17(20)11-3-4-13-12(7-11)8-15(10-1-2-10)14-5-6-18-9-16(13)14;/h3-10H,1-2H2,(H,19,20);/q;+1/p-1
Standard InChI Key: PSJTZNIWJPKGQS-UHFFFAOYSA-M
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
27.0251 -21.8908 0.0000 Na 0 0 0 0 0 15 0 0 0 0 0 0
21.2744 -19.1173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2733 -19.9409 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.9855 -20.3499 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9837 -18.7043 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6964 -19.1137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6972 -19.9368 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1134 -19.1068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4001 -18.6993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1181 -19.9331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4066 -20.3402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4065 -21.1587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1171 -21.5710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8294 -21.1547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8260 -20.3376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5427 -21.5647 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5459 -22.3861 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.2530 -21.1493 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.3910 -17.8821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7950 -17.1717 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9778 -17.1771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 4 1 0
4 7 2 0
6 5 2 0
5 2 1 0
6 7 1 0
7 11 1 0
10 8 1 0
8 9 2 0
9 6 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 10 2 0
14 16 1 0
16 17 2 0
16 18 1 0
20 19 1 0
21 20 1 0
19 21 1 0
9 19 1 0
M CHG 2 1 1 18 -1
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 263.30 | Molecular Weight (Monoisotopic): 263.0946 | AlogP: 3.96 | #Rotatable Bonds: 2 |
Polar Surface Area: 50.19 | Molecular Species: ACID | HBA: 2 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.17 | CX Basic pKa: 5.15 | CX LogP: 2.11 | CX LogD: 0.08 |
Aromatic Rings: 3 | Heavy Atoms: 20 | QED Weighted: 0.71 | Np Likeness Score: 0.07 |
References
1. (2020) Anti-cancer/anti-fibrosis compounds, |